September 19, 2013

Clinical Trial: Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma

Sponsor and Collaborators

Case Comprehensive Cancer Center

National Caner Institute (NCI)

Contact
Henry Koon, MD
216-368-1175

Principal Investigator
Henry Koon, MD
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

ClinicalTrials.gov Identifier
NCT00991991

Next post in Melanoma Clinical Trials

Clinical Trial: Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma (Mel 51)